Skip to content
← All SEBI filings
RHPFiled 17 Mar 2026

Sai Parenteral’s Limited

CIN U24231TG2001PLC036043View full DRHP on SEBI ↗

Restated financials

Metric (₹)FY25FY24FY23
Revenue from operations₹163.1 Cr₹153.8 Cr₹96.8 Cr
Profit after tax---
Total assets---
Total equity---
Total liabilities---
Cash flow from operations---

Consolidated figures extracted from the restated financial statements in the RHP. Always verify against the original prospectus.

Related-party transactions

PartyRelationshipAmount
Noumed Pharmaceuticals Pty Limited--